Skip to content
CellantraTech
  • Home
  • Company
  • Platform
  • Pipeline
  • Press Releases
  • Contact
CellantraTech
  • Home
  • Company
  • Platform
  • Pipeline
  • Press Releases
  • Contact

Press Releases

Press Releases

Company news, development updates and public announcements from Tapanstech Therapeutics.

 

2026
2025

2026

Press releases and company announcements for 2026 will be posted here as they become available.

2025

Press releases and company announcements for 2025 will be posted here as they become available.

 

CellentraTech Files Patent Application Covering W2993, Advancing Intellectual Property Strategy for Lead KRAS G12D Program

cropped-lgogos.png

CellantraTech Therapeutics is a preclinical biotechnology company building a reusable nonviral delivery platform and two co-lead oncology programs.

Company

  • Company Overview
  • Development Approach
  • Current Priorities
  • Press Release

Facilities

  • Reusable Nonviral Delivery
  • Two Co-Lead Programs
  • Engineered-TCR Research
  • Product Quality

Products & Services

  • Preclinical Portfolio
  • Evidence Boundary
  • Validation Framework
  • Therapy

Contact Info

35 Landsdowne Street , Cambridge, MA

info@cellan.com

  • Copyright © 2026 CellantraTech Therapeutics